The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 19, 2014

Filed:

Nov. 02, 2010
Applicants:

Morten Strom, Tromso, NO;

Terkel Hansen, Tromso, NO;

Martina Havelkova, Tromso, NO;

Veronika Torfoss, Krokelvdalen, NO;

Inventors:

Morten Strom, Tromso, NO;

Terkel Hansen, Tromso, NO;

Martina Havelkova, Tromso, NO;

Veronika Torfoss, Krokelvdalen, NO;

Assignee:

Lytix Biopharma AS, Tromso, NO;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A01N 37/18 (2006.01); A61K 38/00 (2006.01); A61P 31/04 (2006.01); A61P 35/00 (2006.01); A61K 38/06 (2006.01); A61K 38/07 (2006.01); A61K 31/4965 (2006.01); A61K 31/165 (2006.01); A61K 31/16 (2006.01); C07C 233/00 (2006.01); C07C 235/00 (2006.01); C07C 237/00 (2006.01); C07C 239/00 (2006.01); A61K 38/04 (2006.01); C07K 5/00 (2006.01); C07K 7/00 (2006.01); C07K 16/00 (2006.01); C07K 17/00 (2006.01); C07D 295/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention provides a peptide, peptidomimetic or amino acid derivative having a net positive charge of at least +2 and incorporating a disubstituted β amino acid, each of the substituting groups in the β amino acid, which may be the same or different, comprises at least (7) non-hydrogen atoms, is lipophilic and has at least one cyclic group, one or more cyclic groups within a substituting group may be linked or fused to one or more cyclic groups within the other substituting group and where cyclic groups are fused in this way the combined total number of non-hydrogen atoms for the two substituting groups is at least (12), for use as a cytolytic therapeutic agent; as well as non therapeutic uses of these molecules and certain defined novel compounds from within this definition.


Find Patent Forward Citations

Loading…